Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of JZC11 intra-articular injection for knee osteoarthritis
CTR20200604Phase 2Completed
- Sponsor
- Shanghai Jingfeng Pharmaceutical
- Start
- May 2020
- Countries
- 1
01
Overview
A Phase 2 trial of JZC11 in knee osteoarthritis (OA), sponsored by Shanghai Jingfeng Pharmaceutical. Started May 2020; status: completed.
02
Drugs
JZC11
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20200604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200604.